Ubs Global Asset Management Americas »

Abcellera Biologics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Abcellera Biologics

Jul 2022Jan 2023Jul 2023Jan 2024Jul 202405M10M01M2M3M4M
Value ($)Share countHistorical ABCL position of Ubs Global Asset … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 4.6M 2.60
2024-06-30 $14M 4.6M 2.96
2022-06-30 $341k 32k 10.65